Trials by Active Ingredient
Tapentadol
| Trial identifier (Sponsor): | KF5503/58 |
| Trade name: | Palexia®, Nucynta®, Yantil® |
| INN / Sponsor substance code: | Tapentadol |
| Trial title: | Evaluation of the effectiveness, safety, and tolerability of tapentadol PR versus a combination of tapentadol PR and pregabalin in subjects with severe chronic low back pain with a neuropathic pain component |
| Brief title: | -- |
| Trial indication: | Severe chronic low back pain with a neuropathic pain component |
| Trial status: | Completed |
| Results posted: | Yes (Clinical Trials.gov, Eudra CT) |
| PubMed unique identifier [PMID]: | 24738609, 24750558 |
| First subject enrolled: | 23 Mar 2011 |
| Last subject completed: | 17 Jan 2012 |
| UTN (WHO): | -- |
| ClinicalTrials.gov identifier: | NCT01352741 |
| Eudra CT identifier: | 2010-019998-14 |
| Available for data sharing: | No |
| Trial phase: | 3b |
